Prostate cancer is the development of?cancer?in the?prostate, a?gland?in the?male reproductive system. The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. In 2017, the global Prostate Cancer Diagnosis and Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global Prostate Cancer Diagnosis and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Diagnosis and Treatment development in United States, Europe and China. The key players covered in this study Abbott Laboratories AbbVie Active Biotech Amgen Astellas Pharma AstraZeneca Bavarian Nordic Bayer? Bristol-Myers Squibb Dendreon Endo Ferring Pharmaceuticals GE Healthcare GSK Ipsen Johnson & Johnson Pfizer Sanofi Siemens?Healthineers Takeda Teva Pharmaceutical Tolmar Pharmaceuticals Market segment by Type, the product can be split into Prostate specific antigen test (PSA) Digital rectal exam (DRE) Market segment by Application, split into Hospitals Diagnostic clinics Research centers Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Prostate Cancer Diagnosis and Treatment status, future forecast, growth opportunity, key market and key players. To present the Prostate Cancer Diagnosis and Treatment development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Prostate Cancer Diagnosis and Treatment are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type (2013-2025) 1.4.2 Prostate specific antigen test (PSA) 1.4.3 Digital rectal exam (DRE) 1.5 Market by Application 1.5.1 Global P
